Alkem Laboratories will open its trading window for designated persons on June 1, 2026, following the communication of its financial results for the quarter and year ended March 31, 2026. The window was previously closed on March 30, 2026, to comply with insider trading regulations ahead of the results announcement. The company confirmed that the results have now been submitted to the stock exchanges, allowing the trading window to reopen after the mandatory 48-hour period post-disclosure.

The closure of the trading window was a procedural measure implemented to prevent insider trading while the financial results were being finalized. The restriction applied to insiders and designated persons associated with Alkem Laboratories . The reopening of the window permits these individuals to trade in the company's securities once again.

The intimation was addressed to the Corporate Relationship Department of BSE Limited and the National Stock Exchange of India Limited. The filing was signed by Manish Narang, President - Legal, Company Secretary & Compliance Officer of Alkem Laboratories Limited.

Alkem Laboratories Limited has scheduled a one-on-one meeting with SBI Mutual Fund on May 29, 2026, in Mumbai. The interaction aims to engage with the institutional investor regarding the company's operations and performance.

The disclosure was made in reference to the relevant provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company specified that the engagement will be an in-person meeting.

Meeting Details

The following table outlines the specifics of the scheduled interaction:

The company noted that the schedule for the aforementioned meeting is subject to change due to exigencies on the part of the investor or the company. The intimation was signed by Manish Narang, President – Legal, Company Secretary & Compliance Officer.